We kind of take for granted these days that embryonic stem cell research can proceed without any restrictions, at least at the federal level. However, in the early days of blogging here on The Niche the big debate and battle were over federal funding of embryonic stem cell research. Things got very complicated and for […]
Lessons from when embryonic stem cell research was illegal Read More »
Here we go again with people trying to ban funding of embryonic stem cell research. Really? Yes, including according to a new article from the Catholic News Agency. Who is trying to get this ban? Some Republicans in The U.S. Senate. I’ve wondered for years if the Trump Administration might take action against embryonic stem
US Senate bill would ban embryonic stem cell research Read More »
The four words “California stem cell research” go nicely together and I hope they will continue to resonate in a special way to people around the world in the coming decade. We are at a crossroads for stem cell research in California as the original form of the California Stem Cell Agency (CIRM) winds down.
The future of California stem cell research & CIRM Read More »
University of Minnesota bioethicist Leigh Turner has been threatened with a lawsuit by a stem cell clinic-related business. Lawsuit threats in this arena come up every so often and as much as they are unpleasant realities, they can also reveal some important aspects of the stem cell arena. Ars Technica reported yesterday that Leigh’s recent paper
Stem cell clinic-related biz threatens researcher with lawsuit, wants retraction Read More »
Should there be a religious or moral litmus test for the NIH Director? A few dozen super conservative Republican members of Congress have written a letter to President Trump saying he should fire NIH Director Francis Collins. Why? Because they claim that Collins is not conservative enough for their taste and in particular they don’t
GOP reps to Trump: fire NIH Director Collins for stem cell research support Read More »
As a stem cell biologist it’s fun to read new papers on the latest cutting edge research. In that spirit, here is a list of 7 recent stem cell and regenerative medicine papers that caught my eye as particularly notable and that have sparked discussion. From PLoS Biology: Manipulating the Germinal Activity of the Brain From Nature
7 cool new stem cell research papers Read More »
By Amritha Jaishankar Happy Maryland Day from the Maryland Stem Cell Research Fund (MSCRF) at Maryland Technology Development Corp. (TEDCO)! This year, here at MSCRF, we are skipping the crabs, old bay and beer and choosing instead to spend the weekend engaged in scientific review! As we commemorate the day the first settlers stepped on to
Guest Post from the Maryland Stem Cell Research Fund Read More »
By Samantha Yammine, PhD Candidate in Derek van der Kooy’s lab at the University of Toronto. See tweets live from #TMM2016 via @SamanthaZY here. Last week, 430 Canadian scientists, trainees, industry professionals, science communicators and international guests gathered in the picturesque ski town of Whistler, British Columbia for the annual Till & McCulloch meeting (TMM).
The FDA’s stem cell meeting wrapped up today on day two with a diverse group of individual speakers. A series of patient testimonials today in favor of clinics was one thing that stood out. You can read my take of day one and the account of Jeanne Loring who was at the meeting. I’ve noted that on
Report on day 2 of FDA stem cell meeting: patients, researchers, & more Read More »
The REGROW Act has attracted both support and criticism, including on this blog, for the changes it would mandate in the way the FDA regulates stem cell products. More specifically it would greatly reduce regulation of experimental stem cell products. I believe that would be dangerous to patients and to the stem cell field more
Is REGROW Act anti-embryo research? Pluripotent stem cells excluded Read More »